On June 25, 2015 Provectus Biopharmaceuticals reported that its poster presentation titled "Trials in Progress: Intralesional Rose Bengal vs Systemic Chemotherapy for Treatment of Locally Advanced Cutaneous Melanoma" is on display at the 5th European Post-Chicago Melanoma / Skin Cancer Meeting in Munich, Germany (Press release, Provectus Pharmaceuticals, JUN 25, 2015, http://www.pvct.com/pressrelease.html?article=20150625.1 [SID:1234505801]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The poster presentation will be open in the Royal Ballroom of the Leonardo Royal Hotel, in Munich, Germany throughout the entirety of the conference. The conference will run June 25-26, 2015.

Additionally, Dr. Vernon Sondak (Moffitt Cancer Center, Tampa, Florida, USA) will present on PV-10 during "Symposium III – New Drugs and Trials I: Immunotherapy" to be held Thursday, June 25, from 17:40 – 17:48 (5:40PM – 5:48PM local time), also in the Royal Ballroom.

To access the poster, visit: http://www.pvct.com/publications/Post-Chicago-Munich-2015.pdf